(Medical Xpress) -- Restoration Robotics Inc., a privately-held medical device company which is based in California, has received FDA approval for their ARTAS System. The ARTAS System, which is designed to harvest the hair ...
Castor oil, which was once used by fascists in Italy as punishment because of its quick-acting laxative effect, is now a weight-loss trend on TikTok. Not drinking it, but rubbing it on your belly.
Aug 4, 2024
0
0
The U.S. Food and Drug Administration has approved Leqselvi (deuruxolitinib) tablets for the treatment of adults with severe alopecia areata.
Aug 3, 2024
0
1
The key to curing male pattern baldness—a condition that affects up to 50% of men worldwide—could lie in a sugar that naturally occurs in the human body, according to scientists at the University of Sheffield.
Jul 22, 2024
0
34
A new model developed by researchers could help inform guidelines and improve evidence-based advice on the risks and benefits of fish consumption, especially during pregnancy.
Jun 28, 2024
0
1
Zhu Yangyang babbles away like a typical happy three-year-old, calling out for "mama" and "papa" and accurately naming colors—a remarkable achievement considering he was completely deaf just months ago.
Jun 8, 2024
0
1
Patients with Cushing's syndrome who are recovering from surgery and wear a headband that tracks brain activity while they meditate may have less pain and better physical functioning compared with patients not using the device, ...
Jun 3, 2024
0
0
In a small pilot study, some young women looking to lose weight on a low-calorie keto diet got an unexpected benefit: Their acne began to clear up.
May 15, 2024
0
0
The Food and Drug Administration (FDA) is expected to ban formaldehyde as an ingredient in chemical hair straighteners, also known as relaxers.
May 14, 2024
0
0
The majority of children and teens with chronic skin diseases such as acne, eczema, psoriasis, alopecia areata (hair loss) and vitiligo (pigment loss) feel stigmatized by peers for their condition and are sometimes bullied, ...
Apr 24, 2024
0
0
